Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2236 to 2250 of 8922 results

  1. ID6611 Obesity, overweight - semaglutide (including review of TA875)

    Awaiting development Reference number: GID-TA11851 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. Semaglutide 7.2 mg single-dose device for managing overweight and obesity [ID6699]

    Awaiting development Reference number: GID-TA11920 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  3. Orforglipron for treating obstructive sleep apnoea associated with obesity or overweight [TSID12323]

    Awaiting development Reference number: GID-TA11916 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Vanzacaftor–tezacaftor–deutivacaftor for treating cystic fibrosis with 1 or more responsive mutations in the CFTR gene in people 2 to 5 years [TSID12296]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  5. Transoral endoscopic thyroid surgery via a vestibular approach

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysfunction (RCPD)

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  7. Oesophageal String Test

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  8. Transoral Endoscopic Thyroid/Parathyroid Vestibular Approach

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  9. Thermocoagulation for the treatment of piles and anal fistula

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  10. Botulinum injection of abdominal wall prior to massive incisional hernia repair

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  11. Percutaneous Laser Ablation (PLA) for benign thyroid nodules

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  12. Capsule endoscopy for oesophageal disease

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  13. Parathyroid autofluorescence and parathyroid angiography

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  14. Dasiglucagon for treating severe hypoglycaemia caused by type 1 diabetes in people under 6 years [TSID12255]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  15. Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation